The role of somatic mutations and cell replication kinetics in quantitative cancer risk assessment.
Moolgavkar
S H
SH
Luebeck
E G
EG
D000251:Adenosine Triphosphatases / Q000032:analysis; D000284:Administration, Oral; D000818:Animals; D015197:Carcinogenicity Tests; D002273:Carcinogens / Q000633:toxicity*; D002455:Cell Division / Q000187:drug effects*; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000473:pathology*; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D009154:Mutation; D009602:Nitrosamines / Q000008:administration & dosage / Q000633:toxicity*; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000473:pathology; D051381:Rats; D012307:Risk Factors
D002273:Carcinogens; D009602:Nitrosamines; C002741:N-nitrosomorpholine; D000251:Adenosine Triphosphatases